InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
20%
T+90 mean return
-6.2%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Vaishnaw Akshay, Président, R&D. Officer active across 3 companies, notably ALNYLAM PHARMACEUTICALS, INC.. Aggregated, 19 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €7.8m. History available since 18 June 2021. The latest transaction was disclosed on 29 May 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
5,130 shares@ US$29.6297100.0% of flowCommon StockSEC:0001415889-25-015001:0
100,000 shares0Common StockSEC:0001104659-25-041460:0
13,500 shares0Common StockSEC:0001415889-24-018649:0
5,082 shares0Common StockSEC:0001735276-23-000076:0
5,312 shares0Common StockSEC:0001735276-23-000045:0
30,913 shares@ US$63.0015.3% of flowCommon StockSEC:0001735276-23-000009:0
1,709 shares@ US$213.132.9% of flowCommon StockSEC:0001735276-23-000009:1
2,307 shares@ US$214.283.9% of flowCommon StockSEC:0001735276-23-000009:2
10,279 shares@ US$215.5917.4% of flowCommon StockSEC:0001735276-23-000009:3
19,447 shares@ US$216.3833.0% of flowCommon StockSEC:0001735276-23-000009:4
4,302 shares@ US$217.057.3% of flowCommon StockSEC:0001735276-23-000009:5
1,124 shares@ US$88.950.8% of flowCommon StockSEC:0001735276-22-000078:0
5,083 shares0Common StockSEC:0001735276-22-000064:0
5,417 shares0Common StockSEC:0001735276-21-000097
5,417 shares0Common StockSEC:0001735276-21-000097:0
10,834 shares@ US$63.000.0015% mcap25.2% of flowCommon StockSEC:0001735276-21-000081:0
10,834 shares@ US$63.004.9% of flowCommon StockSEC:0001735276-21-000081
10,834 shares@ US$63.004.8% of flowCommon StockSEC:0001735276-21-000051
10,834 shares@ US$63.000.0015% mcap24.8% of flowCommon StockSEC:0001735276-21-000051:0
19 of 19 declarations
About Vaishnaw Akshay
Akshay Vaishnaw serves as President of Research and Development at Alnylam Pharmaceuticals, Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and advancement of projects. With a strong background in the pharmaceutical sector, he plays a key role in the strategy for developing new treatments. Akshay Vaishnaw is committed to supporting Alnylam's mission and promoting its success.
